GL1X · GenesisL1 explorer

MolNFT v1 · #119629 · protein

Leishmania major N-myristoyltransferase in complex with a quinoline inhibitor (compound 26).

5G21 · Glycylpeptide N-tetradecanoyltransferase: “Leishmania major N-myristoyltransferase in complex with a quinoline inhibitor (compound 26).”. X-ray diffraction, 3 ligands (MYA, YN4, MG), 2 pockets (best druggability 0.81). MolNFT v1…

PDB
5G21
Type
protein
Length
411 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Glycylpeptide N-tetradecanoyltransferase
EC
2.3.1.97
UniProt
Q4Q5S8
Ligands
MYA, YN4, MG
Pockets
2 · best druggability 0.81

Structure

x-ray diffraction · 1 distinct chain · 31% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGlycylpeptide N-tetradecanoyltransferase (EC 2.3.1.97)protein41131% helix, 28% strandQ4Q5S8

Ligands and binding sites

  • MYA · Tetradecanoyl-coa · ligand · chains A
  • YN4 · Ethyl 4-[(2-cyanoethyl)sulfanyl]-6-{[6-(piperazin-1-yl) · ligand · chains A
  • MG · Magnesium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19050.810.8279MG, MYA, YN4
21290.430.7627empty

Compared structures

  • 5G21 · Leishmania major N-myristoyltransferase in complex with a quinoline inhibitor (compound… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.